Sionna Therapeutics, Inc. - 10-Q Filing
Sionna Therapeutics filed its quarterly report on Form 10-Q for the period ended March 31, 2026. The filing provides financial data including details about preferred stock series (Seed, A, B, C), common stock, additional paid-in capital, and retained earnings as of key dates in 2024, 2025, and 2026.
Tickers: $SION